首页> 美国卫生研究院文献>In Vivo >Salvage Photon or Proton Radiotherapy for Oligo-recurrence in Regional Lymph Nodes After Surgery for Non-small Cell Lung Cancer
【2h】

Salvage Photon or Proton Radiotherapy for Oligo-recurrence in Regional Lymph Nodes After Surgery for Non-small Cell Lung Cancer

机译:非小细胞肺癌手术后区域淋巴结中的寡聚蛋白或质子放射疗法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background/Aim: To evaluate the outcome of definitive salvage radiotherapy (RT) in non-small cell lung cancer (NSCLC) patients with oligo-recurrence in regional lymph nodes after surgery. Patients and Methods: Between January 2003 and December 2016, 33 patients with NSCLC were reviewed from radiotherapy database at our hospital. All patients received photon or proton salvage RT for metastases in the regional lymph nodes. Results: The median follow-up from salvage RT was 35.2 (range=5.9-89.6) months. Recurrences occurred in 18 (55%) patients, and the 3-year overall and progression-free survival rates were 63.8% and 45.1%, respectively. Regional and local control improved patients’ survival and these control rates were increased by use of concurrent chemotherapy (p=0.039) and proton RT (p=0.084). No grade 4 acute or late non-hematologic toxicities were observed. Conclusion: Salvage RT is an effective treatment for NSCLC patients with oligo-recurrence at regional lymph nodes.
机译:背景/目的:在手术后区域淋巴结中的非小细胞肺癌(NSCLC)寡核癌患者中的最终救出放射疗法(RT)的结果。患者及方法:2016年1月至2016年12月,33例NSCLC患者在我们医院的放射治疗数据库中审查。所有患者在区域淋巴结中接受光子或质子挽回转移。结果:Salvage Rt中的中位随访35.2(范围= 5.9-89.6)个月。在18名(55%)患者中发生的再现,3年的总体和无进展的存活率分别为63.8%和45.1%。区域和局部控制改善患者的存活率和这些对照率通过使用并发化疗而增加(P = 0.039)和质子RT(P = 0.084)。没有观察到4级急性或晚期的非血液学毒性。结论:挽救术治疗区域淋巴结在区域淋巴结中的寡聚患者的有效治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号